Coronavirus (COVID-19) - Stay informed with the most recent vaccine information. Learn More

Hero Banner

Ingenuity is at the center of pharmacy care

Welcome to IngenioRx! We are a pharmacy benefit manager focused on people, not just prescriptions. We look at everything through a clinical-first lens, drawing on our pharmacy expertise and deep medical insights. We work to remove barriers, personalize experiences, and improve health outcomes, no matter where our members are in their healthcare journey.


Getting started

You have choices when it comes to managing your prescriptions. Whether you use your local pharmacy or have prescriptions delivered to your door, IngenioRx has you covered. Our digital tools can help you manage your prescriptions. Log in to:

Refill Icon

Refill your prescription

Log in

Price Medication Icon

Price a medication

Log in

Pharmacy Icon

Find a pharmacy

Log in


by the numbers



  • 24/7
    Access to pharmacy experts
  • 92%
    * Specialty pharmacy member satisfaction
  • 34.9%
    ** More care gaps closed from member engagement
  • 3.6%

    *** 2021 overall drug trend Medical + Rx

    Read the full report

Information for


We’re here to help. You can manage your prescriptions, search our drug lists, or contact us. Learn more

Plan sponsors and brokers

Learn how we use our ingenuity to solve issues, lower costs, and help improve our members’ health outcomes. Learn more


We support doctors and pharmacists at every step in our members’ healthcare journey, including digital resources for prior authorization and prescribing. Learn more

The latest from IngenioRx

IngenioRx DrugInsights Q2 2022

IngenioRx’s DrugInsights provides a quarterly summary of Food and Drug Administration (FDA)-approved new molecular entities, formulations, and indications. We continue to closely monitor the FDA landscape to help provide our audiences with an understanding of the current drug and biologic market.

Read Story

2021 IngenioRx Drug Trend Report

How did we keep trend and spend down despite the effects of utilization, inflation, and new drugs introduced to the market? By implementing multiple mitigation strategies — and using our integrated approach to whole-person health.

Read our 2021 Drug Trend Report to learn more.  

Read Story

Q2 2022 IngenioRx Drug & Biologic Pipeline Update

We publish the IngenioRx Drug and Biologic Pipeline Update each quarter to keep our audiences informed about upcoming Food and Drug Administration (FDA) approvals. This newsletter analyzes drugs and biologics in development and other clinical topics of interest. Open the attachment to learn about:

  1. Insights on a gene therapy in development for cerebral adrenoleukodystrophy (CALD).
  2. Potential new treatments for amyotrophic lateral sclerosis (ALS) and psoriasis.
  3. Other select significant product approvals expected in 2022 and 2023.
  4. The latest on Humira® biosimilars and a gene therapy for hemophilia A previously delayed by the FDA.
  5. An update on beta amyloid products for Alzheimer’s disease and a focus on agents for dry age-related macular degeneration (AMD).
Read Story

Stay up to date with the latest from IngenioRx